Related Experiment Videos
[Pharmacokinetic aspects of anti-hypertensive therapy]
Giornale Di Clinica Medica
|June 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial.
Journal of biological regulators and homeostatic agents·2016
Effects of the Antihypertensive Fixed-Dose Combinations on an Early Marker of Hypertensive Cardiac Damage in Subjects at Low Cardiovascular Risk.
American journal of hypertension·2016
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.
Journal of human hypertension·2014
[Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
Giornale di clinica medica·1990
Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning.
Naunyn-Schmiedeberg's archives of pharmacology·2026
AI-Guided Discovery of Natural-Product-Inspired Scaffolds as Dual P-gp/BCRP Inhibitors to Overcome Cancer Multidrug Resistance.
Journal of medicinal chemistry·2026
Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study).
Frontiers in clinical diabetes and healthcare·2026
Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.
Journal of diabetes and metabolic disorders·2026